Adamis Pharmaceuticals Co... (ADMP)
NASDAQ: ADMP
· Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM
Adamis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -20.84M | -25.24M | -25.07M | -26.48M | -31.92M | -39.89M | -40.8M | -45.83M | -57.42M | -52.55M | -54.5M |
Depreciation & Amortization | 568.82K | 967.81K | 1.25M | 1.48M | 1.48M | 822.49K | 1.13M | 1.44M | 1.99M | 3.14M | 3.34M |
Stock-Based Compensation | -204.47K | -129.98K | -643.09K | -340.27K | 138.19K | 216.26K | 1.48M | 1.98M | 2.82M | 3.76M | 4.08M |
Other Working Capital | -1.69M | -4.04M | -4.67M | -4.22M | 505.41K | -2.42M | -10.49M | -11.9M | -5.45M | -743.32K | 7.75M |
Other Non-Cash Items | 13.12M | 13.1M | 3.27M | 1.16M | -1.24M | 5.29M | 7.43M | 15.42M | 22.65M | 16.6M | 19.74M |
Deferred Income Tax | -3.91M | -3.91M | -99.87K | -387.49K | -997.62K | 258.42K | 762.97K | 9.21M | 17.4M | 16.6M | 18.89M |
Change in Working Capital | 5.63M | 2.08M | 832.14K | -1.34M | 882.19K | 622.9K | -9.18M | -10.8M | -6.56M | -3.82M | 6.15M |
Operating Cash Flow | -5.64M | -13.14M | -20.46M | -25.9M | -31.05M | -33.32M | -40.23M | -37.79M | -36.52M | -32.87M | -21.2M |
Capital Expenditures | -91.49K | -299.25K | -653.49K | -680.42K | -816.1K | -756.79K | -844.19K | -1.22M | -977.78K | -883.26K | -1.08M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.23M | 2.21M | 3.45M | 4.16M | 5.31M | 4.44M | 3.07M | 1.51M | 113.81K | n/a | -250K |
Investing Cash Flow | 1.14M | 1.91M | 2.79M | 3.48M | 4.49M | 3.68M | 2.22M | 282.74K | -863.97K | -883.26K | -1.08M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 287.44M | 287.73M | 287.72M | 285M | 242.15K | -2.05M | -2.07M | 53.94M | 53.85M | 66.51M | 69.69M |
Financial Cash Flow | 287.44M | 287.73M | 287.72M | 285M | 242.15K | -2.05M | -2.07M | 53.94M | 53.85M | 66.51M | 69.69M |
Net Cash Flow | -1.78M | -8.24M | -14.67M | -22.14M | -26.31M | -31.74M | -40.13M | 16.4M | 16.38M | 32.76M | 47.42M |
Free Cash Flow | -5.73M | -13.44M | -21.12M | -26.58M | -31.87M | -34.08M | -41.08M | -39.01M | -37.5M | -33.75M | -22.28M |